Key result
For STEMI patients with expected delay in primary PCI, half-dose fibrinolytic therapy followed by urgent transfer for coronary angiography is suggested to reduce total ischemic time.
Why the study?
Does half-dose fibrinolytic therapy followed by urgent transfer for coronary angiography improve outcomes in STEMI patients with expected delay in primary PCI?
Does half-dose fibrinolytic therapy followed by urgent transfer for coronary angiography improve outcomes in STEMI patients with expected delay in primary PCI?
For STEMI patients facing primary PCI delays, a pharmacoinvasive strategy using half-dose fibrinolytics and urgent transfer is suggested to reduce total ischemic time.
Supports half-dose fibrinolysis plus urgent angiography in delayed-PCI STEMI; extends evidence for pharmacoinvasive strategies without routine GPIs.
The primary goal of emergent reperfusion in patients with ST-elevation myocardial infarction (STEMI) is to reduce the total ischemic time (TIT); for STEMI patients in whom there is an expected delay in primary PCI, we suggest the use of half-dose fibrinolytic therapy, followed by urgent transfer for coronary angiography without the routine use of glycoprotein IIB/IIIA inhibitors, as long as the patient is adequately loaded with a P2Y 12 inhibitor and aspirin "
No takes yet. Share an insight, caveat, or question.
Khalid et al. (2018) conducted a review in ST-elevation myocardial infarction (STEMI). Half-dose fibrinolytic therapy followed by urgent transfer for coronary angiography was evaluated on Total ischemic time (TIT). For STEMI patients with expected delay in primary PCI, half-dose fibrinolytic therapy followed by urgent transfer for coronary angiography is suggested to reduce total ischemic time.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: